Cite
Lapachol and (α/β)-lapachone as inhibitors of SARS-CoV-2 Main Protease (Mpro) and hACE-2: ADME properties, docking and dynamic simulation approaches.
MLA
Snoussi, Mejdi, et al. “Lapachol and (α/β)-Lapachone as Inhibitors of SARS-CoV-2 Main Protease (Mpro) and HACE-2: ADME Properties, Docking and Dynamic Simulation Approaches.” Pharmacognosy Magazine, vol. 18, no. 79, July 2022, pp. 773–82. EBSCOhost, https://doi.org/10.4103/pm.pm_251_22.
APA
Snoussi, M., Ahmad, I., Patel, H., Noumi, E., Zrieq, R., Saeed, M., Sulaiman, S., Khalifa, N., Chabchoub, F., De Feo, V., M. Gad-Elkareem, M., Aouadi, K., & Kadri, A. (2022). Lapachol and (α/β)-lapachone as inhibitors of SARS-CoV-2 Main Protease (Mpro) and hACE-2: ADME properties, docking and dynamic simulation approaches. Pharmacognosy Magazine, 18(79), 773–782. https://doi.org/10.4103/pm.pm_251_22
Chicago
Snoussi, Mejdi, Iqrar Ahmad, Harun Patel, Emira Noumi, Rafat Zrieq, Mohd Saeed, Shadi Sulaiman, et al. 2022. “Lapachol and (α/β)-Lapachone as Inhibitors of SARS-CoV-2 Main Protease (Mpro) and HACE-2: ADME Properties, Docking and Dynamic Simulation Approaches.” Pharmacognosy Magazine 18 (79): 773–82. doi:10.4103/pm.pm_251_22.